| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/08/2004 | CA2509423A1 Peptides and their use for the treatment of hiv infections |
| 07/08/2004 | CA2508273A1 Disease treatment via antimicrobial peptide inhibitors |
| 07/08/2004 | CA2507637A1 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/08/2004 | CA2507613A1 Methods of diagnosis and treatment of interstitial lung disease |
| 07/08/2004 | CA2505213A1 Cell-based vegf delivery |
| 07/07/2004 | EP1435387A1 The oncolytic microorganisms expressing hsp and uses thereof |
| 07/07/2004 | EP1435244A1 Drugs ameliorating hypo-hdl cholesterolemia |
| 07/07/2004 | EP1435243A2 Methods of alleviating cancer symtoms |
| 07/07/2004 | EP1435233A1 Cyclosporin-based pharmaceutical compositions |
| 07/07/2004 | EP1434990A2 Method for identifying compounds the specifically deplete mast cells |
| 07/07/2004 | EP1434886A2 Mid 241 receptor, a novel g-protein coupled receptor |
| 07/07/2004 | EP1434885A2 21132, a human g-protein coupled receptor family member and uses therefor |
| 07/07/2004 | EP1434884A2 Single nucleotide polymorphisms predicting cardiovascular disease |
| 07/07/2004 | EP1434882A1 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes |
| 07/07/2004 | EP1434878A2 Nucleic acid constructs capable of high efficiency delivery of polynucleotides into dna containing organelles and methods of utilizing same |
| 07/07/2004 | EP1434876A1 Expression profiling in the intact human heart |
| 07/07/2004 | EP1434865A2 Variants and exons of the glyt1 transporter |
| 07/07/2004 | EP1434860A2 Enzymes |
| 07/07/2004 | EP1434801A2 Treatment for central nervous system disorders |
| 07/07/2004 | EP1434799A2 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans |
| 07/07/2004 | EP1434798A2 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 07/07/2004 | EP1434797A2 Insulin mimetic amino acid sequences |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434794A2 Fragments of heat shock proteins and their use |
| 07/07/2004 | EP1434792A2 Peptidyl ketones as inhibitors of dpiv |
| 07/07/2004 | EP1434791A2 Specific binding agents of human angiopoietin-2 |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434787A2 Lp mammalian proteins; related reagents |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434779A2 Cross-linked glycopeptide-cephalosporin antibiotics |
| 07/07/2004 | EP1434778A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/07/2004 | EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 07/07/2004 | EP1434603A2 Method of treatment using ligand-immunogen conjugates |
| 07/07/2004 | EP1434601A2 Liposome-encapsulated insulin formulations |
| 07/07/2004 | EP1434600A2 Use of lh in controlled ovarian hyperstimulation |
| 07/07/2004 | EP1434599A1 Human 3 relaxin |
| 07/07/2004 | EP1434598A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 07/07/2004 | EP1434597A1 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 07/07/2004 | EP1434595A1 Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom |
| 07/07/2004 | EP1434594A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 07/07/2004 | EP1434590A2 Method for inhibiting the formation of seromas using factor xiii |
| 07/07/2004 | EP1434569A1 Therapeutic biological product and method for formation of new vascularised bone |
| 07/07/2004 | EP1434563A1 Methods for the treatment of hyperpigmentation of skin |
| 07/07/2004 | EP1434561A1 Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof |
| 07/07/2004 | EP1401431A4 Human growth hormone antagonists |
| 07/07/2004 | EP1387884A4 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 07/07/2004 | EP1341550A4 Method for treating respiratory distress syndrome |
| 07/07/2004 | EP1278523B1 Combination of progesterone and mifepristone for cancer therapy |
| 07/07/2004 | EP1100912B1 Method for screening of modulators of calcineurin activity |
| 07/07/2004 | EP1006794A4 A method for treating or preventing alzheimer's disease |
| 07/07/2004 | EP0907373B1 Use of synergistic compositions of il-12 and ifn-alpha for the treatment of infectious diseases |
| 07/07/2004 | EP0876155B1 Highly concentrated, lyophilized and liquid factor ix formulations |
| 07/07/2004 | EP0750743B1 Method and device for automatic assessment of corn |
| 07/07/2004 | CN1511164A Peptides presented by cells |
| 07/07/2004 | CN1511053A HSA-free formulations of interferon-Beta |
| 07/07/2004 | CN1511044A Elogated and multiple spacers in activatible prodrugs |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/07/2004 | CN1511037A Nonintestinal estramustine phosphate and albumin preparations |
| 07/07/2004 | CN1511017A Treating epidermlyosis bullosa with thymosin Beta-4 |
| 07/07/2004 | CN1510147A Determination of alpha-N-acetamino galactosidase activity |
| 07/07/2004 | CN1510137A Gene identification |
| 07/07/2004 | CN1510039A Anti-CD 20 embedded antibody mutant gene and its use |
| 07/07/2004 | CN1509763A Application for human tumour necrosis factor-alpha mutant |
| 07/07/2004 | CN1509762A Use of slaphylococcus aureus enterotoxins in preparing drugs for treating or preventing A1DS |
| 07/07/2004 | CN1509725A Oral staphylococcus aureus filtrate preparation for improving immune function |
| 07/07/2004 | CN1156492C Somatostatin peptides |
| 07/07/2004 | CN1156315C One dose syringe, comprising freeze-dried protein composition, for administering of volume less than 0.5ml |
| 07/07/2004 | CN1156308C Multi-enzyme complex capsule |
| 07/07/2004 | CN1156307C Vagina spry cotaining biological active factor |
| 07/06/2004 | US6759530 IBD-associated microbial nucleic acid molecules |
| 07/06/2004 | US6759520 Containing an opioid peptide moiety and a nociceptive peptide moiety for producing analgesia; used for the treatment of pain |
| 07/06/2004 | US6759519 Nuclelotide sequences coding binding protein; for use in the treatment of nervous system, immunological and psychological disorders; for us as wound healing agent; for use in treatment of allergies, asthma and arthritis |
| 07/06/2004 | US6759518 Single-chain multiple antigen-binding molecule, its preparation and use |
| 07/06/2004 | US6759517 Allergenic proteins of natural rubber latex, their production and use in assays |
| 07/06/2004 | US6759516 Methods of identifying antigen gene sequences |
| 07/06/2004 | US6759515 A prostate-specific protein, and to polynucleotides encoding such polypeptides |
| 07/06/2004 | US6759513 Death domain containing receptors |
| 07/06/2004 | US6759512 Used to treat spinal cord injuries and damage to peripheral nerves by promoting neural- cell adhesion and neurite extension, inhibiting tumor metastases and tumor angiogenesis, stimulating wound repair; prevention of malaria |
| 07/06/2004 | US6759509 Branched peptide linkers |
| 07/06/2004 | US6759508 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/06/2004 | US6759432 Prevent denaturing of collagen |
| 07/06/2004 | US6759424 Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them |
| 07/06/2004 | US6759420 Low molecular weight, factor xa specific blood clotting inhibitors without side effects |
| 07/06/2004 | US6759404 Inhibiting gamma-secretase activity; treating diseases associated with beta-amyloid production, such as alzheimer's disease |
| 07/06/2004 | US6759393 Growth hormone and growth hormone releasing hormone compositions |
| 07/06/2004 | US6759389 Purified recombinant protein consisting of amino acid sequence 3; axonal regeneration; accelerating wound healing while minimizing scar tissue and keloid formation keloid formation. |
| 07/06/2004 | US6759387 Delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue |
| 07/06/2004 | US6759386 Clinical assay of cpk-mb (crreatine phosphokinase-myocardial band) levels in a patient undergoing treatment with growth factor proteins. |
| 07/06/2004 | US6759385 Methods to treat undesirable immune responses |
| 07/06/2004 | US6759384 Factor Xa inhibitors |
| 07/06/2004 | US6759242 Low oxygen culturing of neural crest stem cells and methods of use |
| 07/06/2004 | US6759240 Methods for purifying actin |
| 07/06/2004 | US6759236 For gene therapy of restricted areas e.g. tumors |
| 07/06/2004 | US6759234 Used to treat protein allergen sensitivity in humans |
| 07/06/2004 | US6759229 Contacting a bacterial cell lysogenic for the selected bacteriophage genome with the isolated nucleic acid molecule such that the isolated nucleic acid is introduced into the bacterial cell; allowing it to recombine with genome |
| 07/06/2004 | US6759227 Caspase homologue |
| 07/06/2004 | US6759215 Method of preparing human stem cell factor polypeptide |
| 07/06/2004 | US6759214 Methods and compositions relating to CD39-like polypeptides and nucleic acids |
| 07/06/2004 | US6759213 Haemophilus adhesion proteins |
| 07/06/2004 | US6759211 For cancer use in therapy |